NASDAQ
BioNexus Gene Lab Corp. (BGLC) has a revenue compound annual growth rate of -8.20% over 5 years. Revenue CAGR shows the compound annual growth rate of a company's total sales, indicating the pace of top-line expansion.
No price data available for this timeframe.